Please ensure Javascript is enabled for purposes of website accessibility
Chimerix Stock Quote

Chimerix (NASDAQ: CMRX)

$1.77
(0.0%)
$0.00
Price as of January 31, 2023, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Chimerix Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
CMRX -67.28% -63.05% -18.05% -91%
S&P -9.34% +42.28% +7.31% +156%

Chimerix Company Info

Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157.

News & Analysis

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
395%
 
S&P 500 Returns
117%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 02/01/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.